Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin beta 19 pseudogene (PCDHB19P, also known as PCDH-PSI5) is a non-functional genetic element within the human protocadherin beta gene cluster on chromosome 5[2]. The protocadherin beta gene cluster contains both protein-coding genes and multiple pseudogenes, with the pseudogenes not encoding active proteins. Protocadherins in general are part of the cadherin superfamily and are involved in neural cell adhesion, but PCDHB19P is not transcribed into a protein and has no known physiological or pathological function[2]. This locus is not considered a molecular target for therapeutic intervention or pharmacological modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin beta 19 pseudogene (PCDHB19P).